Exane Derivatives’s iShares Silver Trust SLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$14.9K Hold
799
0.01% 377
2022
Q1
$18.3K Sell
799
-4,000
-83% -$88.9K 0.01% 666
2021
Q4
$103K Hold
4,799
0.03% 438
2021
Q3
$98.5K Sell
4,799
-4,852
-50% -$109K 0.02% 527
2021
Q2
$232K Sell
9,651
-7,713
-44% -$191K 0.05% 360
2021
Q1
$394K Hold
17,364
0.11% 179
2020
Q4
$427K Sell
17,364
-5,517
-24% -$125K 0.13% 190
2020
Q3
$495K Buy
22,881
+962
+4% +$21.9K 0.14% 131
2020
Q2
$373K Buy
21,919
+12,075
+123% +$185K 0.1% 175
2020
Q1
$128K Sell
9,844
-211,456
-96% -$3.32M 0.04% 250
2019
Q4
$3.72M Buy
221,300
+221,200
+221,200% +$3.58M 0.69% 38
2019
Q3
$1.59K Sell
100
-24,800
-100% -$394K ﹤0.01% 508
2019
Q2
$357K Buy
+24,900
New +$348K 0.06% 204

Other funds holding SLV

Exane Derivatives's SLV Position: Q2 2022 in Review

Exane Derivatives held its iShares Silver Trust (SLV) position steady in Q2 2022 at 799 shares worth $14.9K. The position accounts for 0.01% of the portfolio, ranked #377.

Exane Derivatives first reported a position in SLV in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.72M in Q4 2019. 692 funds tracked by Wall St. Rank hold SLV as of Q2 2022.

  • Exane Derivatives held 799 shares of iShares Silver Trust worth $14.9K as of Q2 2022.
  • Exane Derivatives left its iShares Silver Trust share count unchanged in Q2 2022.
  • iShares Silver Trust made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #377 holding.
  • Exane Derivatives first reported a position in iShares Silver Trust in Q2 2019 and has held it in 13 quarters since.
  • Exane Derivatives's iShares Silver Trust position peaked at $3.72M in Q4 2019.
  • 692 funds tracked by Wall St. Rank held iShares Silver Trust as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.